ALX Oncology Holdings Inc.
ALXO
$0.5215
-$0.0202-3.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 16.16% | -11.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.00% | -21.57% | |||
| Operating Income | 6.00% | 21.57% | |||
| Income Before Tax | 5.03% | 22.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.03% | 22.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.03% | 22.06% | |||
| EBIT | 6.00% | 21.57% | |||
| EBITDA | 6.02% | 20.83% | |||
| EPS Basic | 5.22% | 23.34% | |||
| Normalized Basic EPS | 5.22% | 23.34% | |||
| EPS Diluted | 5.22% | 23.34% | |||
| Normalized Diluted EPS | 5.22% | 23.34% | |||
| Average Basic Shares Outstanding | 0.21% | 1.66% | |||
| Average Diluted Shares Outstanding | 0.21% | 1.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||